Continuous low‐dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15482
Abstract: The aim of our retrospective study was to evaluate the efficacy of a continuous therapy with a lower dosage of gemcitabine compared to those usually administered in patients with cutaneous T cell lymphomas (CTCL). Twenty‐two… read more here.
Keywords: dose gemcitabine; retrospective study; gemcitabine; cutaneous cell ... See more keywords
Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy
Sign Up to like & getrecommendations! Published in 2019 at "AntiCancer Research"
DOI: 10.21873/anticanres.13726
Abstract: Background/Aim: Gemcitabine is standard first-line treatment for patients with advanced pancreatic cancer, however the efficacy is limited. Although acquired drug resistance and side-effects are known to limit efficacy, opposite effects of a drug, which enhance… read more here.
Keywords: low dose; orthotopic; gemcitabine; metastasis ... See more keywords
R0 Resection for Locally Advanced Pancreatic Cancer with Low-dose Gemcitabine with Wide Irradiation Area as Neoadjuvant Chemoradiotherapy
Sign Up to like & getrecommendations! Published in 2018 at "In Vivo"
DOI: 10.21873/invivo.11362
Abstract: Background: Local antitumor efficacy and the outcome of neoadjuvant chemoradiotherapy (NACRT) with low-dose gemcitabine and wide irradiation area for borderline resectable and unresectable pancreatic cancer were evaluated. Patients and Methods: Thirty-four cases of borderline resectable… read more here.
Keywords: irradiation area; low dose; wide irradiation; pancreatic cancer ... See more keywords